OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview
Joana Figueiredo, Mojgan Djavaheri‐Mergny, Lucille Ferret, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103808-103808
Open Access | Times Cited: 7
Joana Figueiredo, Mojgan Djavaheri‐Mergny, Lucille Ferret, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103808-103808
Open Access | Times Cited: 7
Showing 7 citing articles:
Effects of hydrazone-based G-quadruplex ligands on FANCJ/BRIP1-depleted cancer cells and a Caenorhabditis elegans dog-1−/− strain
Marcello Germoglio, Federica D’Aria, Giuseppe Cortone, et al.
NAR Cancer (2025) Vol. 7, Iss. 1
Open Access
Marcello Germoglio, Federica D’Aria, Giuseppe Cortone, et al.
NAR Cancer (2025) Vol. 7, Iss. 1
Open Access
Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy
Jiahui Lin, Zhu Gong, Yen‐Shen Lu, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1805-1805
Open Access
Jiahui Lin, Zhu Gong, Yen‐Shen Lu, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1805-1805
Open Access
Targeting shelterin proteins for cancer therapy
Wioletta Brankiewicz, Anoop Kallingal, Radosław Krzemieniecki, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104056-104056
Closed Access | Times Cited: 3
Wioletta Brankiewicz, Anoop Kallingal, Radosław Krzemieniecki, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104056-104056
Closed Access | Times Cited: 3
Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme
Hemanathan Elango, Rabindra Nath Das, Abhijit Saha
Future Medicinal Chemistry (2024), pp. 1-25
Closed Access | Times Cited: 1
Hemanathan Elango, Rabindra Nath Das, Abhijit Saha
Future Medicinal Chemistry (2024), pp. 1-25
Closed Access | Times Cited: 1
Synthesis of 1,10‐phenanthroline‐2,9‐bistriazoles: Evaluation as G‐quadruplex binders and anti‐tumor activity
Joana Figueiredo, Israel Carreira‐Barral, Pedro Lourenço, et al.
ChemMedChem (2024)
Closed Access | Times Cited: 1
Joana Figueiredo, Israel Carreira‐Barral, Pedro Lourenço, et al.
ChemMedChem (2024)
Closed Access | Times Cited: 1
9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop2-yne-1-yl]anthracene: G-Quadruplex Selectivity and Anticancer Activity
Margrate Anyanwu, Matteo Giannangeli, Xing‐Xing Fan, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1615-1619
Closed Access
Margrate Anyanwu, Matteo Giannangeli, Xing‐Xing Fan, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1615-1619
Closed Access
Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges
Jéssica Lopes‐Nunes, Paula A. Oliveira, Carla Cruz
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 781-797
Closed Access
Jéssica Lopes‐Nunes, Paula A. Oliveira, Carla Cruz
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 781-797
Closed Access
